Welcome message
Greetings from the 17th International Symposium on IgA Nephropathy
We are pleased to announce that the 17th International Symposium on IgA Nephropathy will be held at KFC Hall & Rooms (Ryogoku, Japan) from September 28 (Thursday) to 30 (Saturday), 2023. The three-day pre-conference period from September 25 (Mon.) to 27 (Wed.) will be designated as IgA Nephropathy Week, and various programs are being planned and prepared for this event.
IgA nephropathy is the most common form of glomerulonephritis in the world, especially in East Asia, including Japan. It has been still the leading cause of end-stage renal failure (ESKD) in many countries around the world. However, the pathogenesis of ESKD has not been fully elucidated, and many researchers around the world are continuing their studies. On the other hand, many promising therapeutic agents have been developed in recent years, and some international clinical studies are currently underway.
The International IgAN Symposium is held every two to three years, and this will be the 17th time symposium and it has been 17 years since last held in Japan. With new corona virus, COVID19, infections showing signs of slowing down worldwide, we plan to hold the symposium in a hybrid format, with between a local venue for the first time in five years and an online venue. The symposium is planned to invite not only physicians and basic/clinical researchers, but also various stakeholders including patients and young people who will lead the next generation.
This symposium is the most important meeting to present the latest findings on the pathogenesis and treatment of IgAN and to exchange opinions. A pre-conference meeting is also planned to provide a forum for the exchange of information between the many key players involved in the disease and those involved in the on-going international clinical trials in order to bring an effective treatment to patients as soon as possible.
The symposium would welcome the participation of not only clinicians and basic researchers involved in IgA nephropathy treatment, but also young doctors, patients, and many people involved in the development of therapeutic drugs.
We look forward to seeing you in Tokyo in September 2023.
Autumn, 2022